+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07432659

Evaluating the ZIDA Control Sock as a Weekly Home Treatment Added to Stable Medication for Adults with Overactive Bladder with Urinary Leakage

Led by Medical University of South Carolina · Updated on 2026-05-06

20

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of the ZIDA Control Sock, an FDA-cleared, noninvasive wearable device that delivers mild electrical stimulation near the ankle, as an additional treatment for adults with overactive bladder OAB who continue to have symptoms despite stable medication. The study focuses on adults diagnosed with OAB-wet, which includes urgency urinary incontinence, to assess the devices effects alongside their usual pharmacologic therapy. Participants will use the ZIDA Control Sock at home once a week for 12 weeks while continuing their prescribed OAB medication. The device stimulates peripheral nerves involved in bladder control through low-level electrical signals. The study is a single-arm clinical investigation that includes participant training, remote support for proper device use, and safety monitoring during the treatment period. Throughout the study, participants will complete bladder diaries, questionnaires, and attend follow-up visits. Researchers will collect clinical and patient-reported information to measure changes in daily urgency urinary incontinence episodes and other bladder symptoms. Safety will be monitored, and device usability and patient impressions of improvement will be evaluated. The study duration is 12 weeks with ongoing assessment of device-related effects.

CONDITIONS

Brief Title

Add-On ZIDA Sock Therapy for Overactive Bladder

Research Team

L

Louisa Keil

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here